Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-17-000005
Filing Date
2017-11-13
Accepted
2017-11-13 16:31:33
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q310q.htm 10-Q 628877
2 EXHIBIT 31.1 a2017q3ex311.htm EX-31.1 12237
3 EXHIBIT 31.2 a2017q3ex312.htm EX-31.2 12241
4 EXHIBIT 32.1 a2017q3ex321.htm EX-32.1 6426
5 EXHIBIT 32.2 a2017q3ex322.htm EX-32.2 6506
12 v471975_img01.jpg GRAPHIC 12313
  Complete submission text file 0001659617-17-000005.txt   3985391

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbrx-20170930.xml EX-101.INS 615971
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbrx-20170930.xsd EX-101.SCH 43215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbrx-20170930_cal.xml EX-101.CAL 36024
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbrx-20170930_def.xml EX-101.DEF 190360
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbrx-20170930_lab.xml EX-101.LAB 544253
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbrx-20170930_pre.xml EX-101.PRE 294167
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 171196359
SIC: 2834 Pharmaceutical Preparations